Children's Place Gets Up to $282 Million in Chapter 11 Financing; Nasdaq Delisting

Nasdaq will suspend trading in the company's stock at the opening of business on Nov. 16, and the company said it will not appeal the decision.

Stock reaction: PLCE shares closed down 6.9% at $0.27 on Nov. 16, from Nov. 13's close of $0.29. The S&P 500 was down 1.9% that day.

Children long sleeve shirts on hangers in a store
Photo: high fliers/Shutterstock.com

Key points

  • Up to $166 million ABL facility with Wells Fargo and up to $116 million term loan with Crystal Financial/SLR
  • Interim outstanding obligations generally expected to be capped at $131 million
  • Final court approval of the financing due by Dec. 15, 2026; sale closing by Dec. 31
  • Nasdaq trading suspension at the opening of business on Nov. 16; company will not appeal

The Children's Place Inc. (Nasdaq: PLCE) said in an 8-K filed Monday that it has secured debtor-in-possession financing of up to $166 million on an asset-based revolver and up to $116 million on a term loan while it proceeds through Chapter 11, and that Nasdaq has determined to delist its securities.

The company and its subsidiaries filed Chapter 11 petitions on Nov. 8 in the U.S. Bankruptcy Court for the District of New Jersey. We reported the filing and the planned sale of substantially all assets on Nov. 9. This latest filing covers the financing that supports the case and the stock exchange action.

Financing terms and size

The revolving credit agreement is with Wells Fargo Bank, National Association, and the term loan is with Crystal Financial LLC, doing business as SLR Credit Solutions. The company said interim outstanding obligations are generally expected to be capped at $131 million, and ABL availability depends on borrowing bases, reserves and other conditions.

Of the $16 million of new-money term loans, $15 million must repay prepetition revolving loans. A $16 million cashless roll-up of prepetition term principal took effect upon interim approval, and the rest of the prepetition term debt is to be rolled up after final court approval.

For scale, the company reported $7.2 million in cash and equivalents as of Aug. 1, and its net loss for the fiscal year ended Jan. 31, 2026 was $88.3 million, compared with $57.8 million a year earlier.

Borrowing costs and deadlines

ABL loans bear interest at the U.S. base rate or Canadian base rate plus 3.50%, with a 0% floor. Term loans bear interest at one-month Term SOFR with a 2.00% floor, plus 8.25%. Default interest generally adds 2.00%.

The scheduled outside maturities are Jan. 29, 2027 for the ABL facility and March 1, 2027 for the term facility. Both can end earlier on specified events, including plan effectiveness, a sale of substantially all assets, or failure to obtain a final order approving the facilities by Dec. 15, 2026.

Restructuring milestones and the Nasdaq decision

The company listed milestones of an auction by Dec. 14, 2026, sale approval by Dec. 17, and any applicable sale closing by Dec. 31, 2026, subject to modification provisions. Missed milestones, payment or covenant defaults and certain other events may lead to termination, acceleration and collateral remedies, subject to cure provisions and a generally applicable three-business-day remedies notice period.

Nasdaq's staff notified the company on Nov. 9 that it had determined to delist the common stock, citing the chapter 11 filing, concerns about the residual equity interest of existing holders, and concerns about the company's ability to sustain compliance with listing requirements. Trading will be suspended at the opening of business on Nov. 16, and a Form 25-NSE will be filed with the SEC. The company said it has decided not to appeal.

The stock last closed at $0.28 on Nov. 13, which put the market value at about $6.2 million before the filing. The company did not say what recovery, if any, holders of its equity would receive. Its filing warns that there can be no assurance it will obtain final financing approval or complete a sale on the required timetable.

Sources

Written with AI from the company's SEC filing and our market data, and checked against those sources before publishing. Our editorial standards.

PLCE page →